A type of stem cell found in early embryos, which is capable of developing into all (totipotent) or a wide range of (pluripotent) different body tissues.
Prominent Republicans have spoken out against recommendations on the federal funding of embryo research made last month by President Clinton's National Bioethics Advisory Commission. A major battle looks likely when Congress considers the annual budget for the Department of Health and Human Services this summer. The Commission's report urges Congress...
This week's BioNews includes a story from the United States that the National Bioethics Advisory Commission is about to publish recommendations that federal funds be made available for some human embryo research. A congressional ban, in place since 1994, has meant that no federal money can be used to fund...
This week's BioNews reports on news that the American biotech company which funded last year's stem cell breakthrough has bought the commercial arm of the Roslin Institute. With the new acquisition, the Geron Corporation will now be able to marry the nuclear transfer technology developed at Roslin with the American...
Research using cloned human embryos should be allowed for the development of tissue and cell therapies, the Australian Academy of Science (AAS) declared in a statement released last week. The AAS statement says that because of recent breakthroughs in the isolation of embryonic stem cells and the development of cloning...
An article in Newsweek discusses the ethical issues surrounding the use of cloning technology to produce embryonic stem cells capable of producing cells and tissues for transplant purposes. The writer makes a distinction between reproductive cloning and the use of cloning technology for therapeutic purposes. The Independent on Sunday deals...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
